Jci_page_head_homepage_01 Jci_page_head_homepage_02
Decheng Ren, Yingjiang Zhou, David Morris, Minghua Li, Zhiqin Li, Liangyou Rui
Published in Volume 117, Issue 2
J Clin Invest. 2007; 117(2):397–406 doi:10.1172/JCI29417
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 6
Neuron-specific overexpression of SH2B1 dose-dependently reduces HFD-induced leptin resistance and obesity.

(A) Brain extracts were prepared from WT, SH2B1TgKO-437, SH2B1Tg/Tg-437, SH2B1Tg-407, SH2B1Tg/Tg-407, and SH2B1Tg-407/437 males, immunoprecipitated with α-SH2B1, and immunoblotted with α-Myc. Extracts were also immunoblotted with anti–β-actin. Each lane represents a sample from 1 mouse. (B) Growth curves for male mice (WT, SH2B1Tg-407, SH2B1Tg/Tg-407, and SH2B1Tg-407/437) fed normal chow or HFD as indicated. (C) Fat content in male mice (16 weeks old) fed an HFD for 9 weeks. (D) Fasting plasma leptin levels in male mice fed standard chow (WT and SH2B1Tg/Tg-437; 17 weeks old) or HFD for 7 weeks (WT, SH2B1Tg/Tg-407, SH2B1Tg/Tg-437, and SH2B1Tg-407/437; 14 weeks old). *P < 0.05.